Quest Diagnostics Incorporated (DGX)
Receivables turnover
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (ttm) | US$ in thousands | 9,872,000 | 9,539,000 | 9,346,000 | 9,287,000 | 9,252,000 | 9,297,000 | 9,488,000 | 9,603,000 | 9,883,000 | 10,294,000 | 10,582,000 | 10,679,000 | 10,788,000 | 11,046,000 | 11,058,000 | 10,335,000 | 9,437,000 | 8,361,000 | 7,531,000 | 7,657,000 |
| Receivables | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Receivables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
Receivables turnover = Revenue (ttm) ÷ Receivables
= $9,872,000K ÷ $—K
= —
The data provided for Quest Diagnostics Incorporated's receivables turnover ratio is consistent with the industry standards, showing no specific values reported for the periods from March 31, 2020, to December 31, 2024. The absence of values indicates a lack of specific information on the company's receivables turnover ratio for the mentioned periods.
As receivables turnover is a key metric in evaluating a company's efficiency in collecting its accounts receivable, the missing data makes it challenging to assess Quest Diagnostics' performance in this area. The receivables turnover ratio is typically calculated as net credit sales divided by average accounts receivable, measuring how many times a company collects its average accounts receivable balance during a specific period.
Without the actual values for Quest Diagnostics' receivables turnover over time, it becomes difficult to gauge the effectiveness of the company's credit and collection policies, as well as its overall liquidity and cash flow management. Analysts and investors often rely on this ratio to understand how well a company manages its accounts receivable and its ability to convert credit sales into cash.
Therefore, the absence of specific data on Quest Diagnostics' receivables turnover ratio limits the depth of analysis that can be conducted in assessing the company's financial performance in terms of accounts receivable management. Investors and stakeholders may seek further information or updates on this ratio to gain a more accurate picture of the company's operational efficiency and financial health.
Peer comparison
Dec 31, 2024